3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Lymphocytic, Chronic, B-Cell
45
Lymphoma, Mantle-Cell
23
Lymphoma, Non-Hodgkin
15
Lymphoma, Large B-Cell, Diffuse
14
Lymphoma, Follicular
10
Waldenstrom Macroglobulinemia
9
Lymphoma
9
Lymphoma, B-Cell, Marginal Zone
7
Leukemia
7
Recurrence
6
Neoplasms
6
Lymphoma, B-Cell
5
Leukemia, B-Cell
5
Bronchiolitis Obliterans Syndrome
5
Multiple Myeloma
3
Leukemia, Prolymphocytic
3
Leukemia, Lymphoid
3
Hematologic Diseases
3
Graft vs Host Disease
3
Burkitt Lymphoma
3
Melanoma
2
Leukemia, Hairy Cell
2
Hematologic Neoplasms
2
Glioblastoma
2
Brain Neoplasms
2
Squamous Cell Carcinoma of Head and Neck
1
Prostatic Neoplasms, Castration-Resistant
1
Primary Central Nervous System Lymphoma (PCNSL)
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Neurologic Manifestations
1
Interventions
Curcumin
3
piperine
1
Urination
1
Tissue Banks
1
Probiotics
1
Metformin
1
Docosahexaenoic Acids
1
Diet, Plant-Based
1
Diet, Mediterranean
1
Blood Specimen Collection
1
Biopsy
1
Absorptiometry, Photon
1
4-(N-methylamino)-4'-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)stilbene
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Monoclonal Gammopathy of Undetermined Significance
×
ibrutinib
×
1 year
×
Clear all
No trials found.